Monitoring of risk factor/outcome combinations: a valuable supplement to birth defect monitoring.
暂无分享,去创建一个
[1] P Mastroiacovo,et al. An ICBDMS collaborative study: monitoring multimalformed infants. , 1991, The International journal of risk & safety in medicine.
[2] S E Vollset,et al. Statistical methods for surveillance of congenital malformations: when do the data indicate a true shift in the risk that an infant is affected by some type of malformation? , 1991, The International journal of risk & safety in medicine.
[3] B. Laumon,et al. Ovulation induction and neural tube defects: a registry study. , 1991, Reproductive toxicology.
[4] FranzW. Rosa. Ovulation induction and neural tube defects , 1990, The Lancet.
[5] H. Jick,et al. Ovulation induction and neural tube defects. , 1990, Teratology.
[6] H. Hoffman,et al. Risk of neural tube defects in relation to maternal fertility and fertility drug use , 1990, The Lancet.
[7] M. Celiloğlu,et al. OVULATION INDUCTION AND NEURAL TUBE DEFECTS , 1989, The Lancet.
[8] N. Wald,et al. OVULATION INDUCTION AND NEURAL TUBE DEFECTS , 1989, The Lancet.
[9] A. Czeizel. OVULATION INDUCTION AND NEURAL TUBE DEFECTS , 1989, The Lancet.
[10] M. Cornel,et al. OVULATION INDUCTION AND NEURAL TUBE DEFECTS , 1989, The Lancet.
[11] Lammer Ej,et al. Teratogen update: valproic acid. , 1987, Teratology.
[12] E. Robert,et al. MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS , 1982, The Lancet.
[13] F. Vogel,et al. Human Genetics: Problems and Approaches , 1979 .